Brief: Julian Singer Says On Jan 26, 2022, JDS1 LLC Delivered Letter To Catalyst Biosciences’S Board

Gyre Therapeutics

27/01/2022 17:11

Jan 27 (Reuters) - Catalyst Biosciences Inc  CBIO.O :
    * JULIAN SINGER SAYS ON JAN 26, 2022, JDS1 LLC DELIVERED A
LETTER
TO CATALYST BIOSCIENCES’S BOARD, GOVERNANCE AND NOMINATING
COMMITTEE - SEC FILING
    * JULIAN SINGER SAYS IN THE LETTER, SEEKING VOLUNTARY
CHANGES TO
CATALYST BIOSCIENCES' BOARD AND URGENT GOVERNANCE REFORMS
    * JULIAN SINGER SAYS IN THE LETTER, SEEK THE IMMEDIATE END
TO
STOCK OFFERINGS THAT DEPRESS CATALYST BIOSCIENCES' STOCK PRICE
    * JULIAN SINGER SAYS IN THE LETTER, URGES AUGUSTINE LAWLOR
TO STEP
DOWN AS CHAIRMAN OF CATALYST BIOSCIENCES

Further company coverage:  CBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))